54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 08
00:20 UTC
|
MSTR
Strategy
|
◎ Target | Dan Dolev ★★★☆☆ #1445 | Outperform | $265.00→ $213.00-19.6% |
|
Jul 08
00:20 UTC
|
MS
Morgan Stanley
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $214.00→ $255.00+19.2% |
|
Jul 08
00:20 UTC
|
MS
Morgan Stanley
|
◎ Target | Ebrahim Poonawala ★★★☆☆ #1726 | Buy | $225.00→ $250.00+11.1% |
|
Jul 08
00:20 UTC
|
MRNA
Moderna
|
◎ Target | Luca Issi ★★★☆☆ #1373 | Sec→ r Perform | $38.00→ $45.00+18.4% |
|
Jul 08
00:20 UTC
|
MRNA
Moderna
|
◎ Target | Dimple Gosai ★★★★☆ #873 | Underperform | $34.00→ $38.00+11.8% |
|
Jul 08
00:20 UTC
|
MORN
Morningstar
|
◎ Target | Alex Kramm ★★★★☆ #743 | Buy | $280.00→ $260.00-7.1% |
|
Jul 08
00:20 UTC
|
MO
Altria Group
|
◎ Target | Faham Baig ★☆☆☆☆ #2936 | Buy | $76.00→ $79.00+3.9% |
|
Jul 08
00:20 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Lisa Walter ★★☆☆☆ #2771 | Outperform | $142.00→ $148.00+4.2% |
|
Jul 08
00:20 UTC
|
MGY
Magnolia Oil & Gas
|
◎ Target | Gabe Daoud not yet tracked | Hold | $34.00→ $32.00-5.9% |
|
Jul 08
00:20 UTC
|
MET
MetLife
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Overweight | $93.00→ $94.00+1.1% |
|
Jul 08
00:20 UTC
|
MCO
Moody's
|
◎ Target | Jeffrey Silber ★★★☆☆ #1673 | Market Perform | $489.00→ $515.00+5.3% |
|
Jul 08
00:20 UTC
|
MCO
Moody's
|
◎ Target | Toni Kaplan ★★★☆☆ #1611 | Equal Weight | $491.00→ $496.00+1.0% |
|
Jul 08
00:20 UTC
|
MANE
Veradermics
|
◎ Target | Roger Song ★★★★☆ #532 | Buy | $138.00→ $182.00+31.9% |
|
Jul 08
00:20 UTC
|
MA
Mastercard
|
◎ Target | Bryan C. Bergin not yet tracked | Buy | $671.00→ $664.00-1.0% |
|
Jul 08
00:20 UTC
|
MA
Mastercard
|
◎ Target | David Koning ★★★★☆ #536 | Outperform | $660.00→ $680.00+3.0% |
|
Jul 08
00:20 UTC
|
LUV
Southwest Airlines
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1134 | Neutral | $44.00→ $55.00+25.0% |
|
Jul 08
00:20 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Chris Schott ★★★☆☆ #1808 | Overweight | $1,300.00→ $1,400.00+7.7% |
|
Jul 08
00:20 UTC
|
LGO
Largo
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $2.80→ $2.40-14.3% |
|
Jul 08
00:20 UTC
|
LGN
Logan Energy
|
◎ Target | firm only | Outperform | C$1.50→ C$1.75+16.7% |
|
Jul 08
00:20 UTC
|
LEGN
Legend Biotech
|
◎ Target | Leonid Timashev ★★☆☆☆ #2314 | Outperform | $64.00→ $63.00-1.6% |
|
Jul 08
00:20 UTC
|
LDOS
Leidos
|
◎ Target | Gautam Khanna ★★★☆☆ #1840 | Hold | $160.00→ $115.00-28.1% |
|
Jul 08
00:20 UTC
|
KLAR
Klarna Group
|
◎ Target | Moshe Orenbuch ★★☆☆☆ #2295 | Hold | $17.00→ $19.00+11.8% |
|
Jul 08
00:20 UTC
|
KEY
KeyCorp
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $25.00→ $27.00+8.0% |
|
Jul 08
00:20 UTC
|
JXN
Jackson Financial
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Overweight | $136.00→ $139.00+2.2% |
|
Jul 08
00:20 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $375.00→ $384.00+2.4% |
|
Jul 08
00:20 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | Ebrahim Poonawala ★★★☆☆ #1726 | Buy | $362.00→ $408.00+12.7% |
|
Jul 08
00:20 UTC
|
JBLU
JetBlue Airways
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1134 | Neutral | $5.00→ $6.00+20.0% |
|
Jul 08
00:20 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $256.00→ $254.00-0.8% |
|
Jul 08
00:20 UTC
|
JAN
JAN
|
◎ Target | Richard Hightower ★★★☆☆ #1851 | Overweight | $30.00→ $33.00+10.0% |
|
Jul 08
00:20 UTC
|
ITUB
Itau Unibanco
|
◎ Target | Domingos Falavina not yet tracked | Overweight | $9.00→ $10.00+11.1% |
|
Jul 08
00:20 UTC
|
INCY
Incyte
|
◎ Target | Brian Abrahams ★★☆☆☆ #2651 | Sec→ r Perform | $95.00→ $99.00+4.2% |
|
Jul 08
00:20 UTC
|
IHRT
iHeartMedia
|
◎ Target | Jessica Reif Cohen not yet tracked | Neutral | $6.00→ $5.00-16.7% |
|
Jul 08
00:20 UTC
|
IDYA
IDEAYA Biosciences
|
◎ Target | Leonid Timashev ★★☆☆☆ #2314 | Outperform | $53.00→ $48.00-9.4% |
|
Jul 08
00:20 UTC
|
IDYA
IDEAYA Biosciences
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $65.00→ $63.00-3.1% |
|
Jul 08
00:20 UTC
|
ICE
Intercontinental Exchange
|
◎ Target | Alex Kramm ★★★★☆ #743 | Buy | $205.00→ $190.00-7.3% |
|
Jul 08
00:20 UTC
|
HWC
Hancock Whitney
|
◎ Target | Jared Shaw ★★☆☆☆ #2545 | Overweight | $76.00→ $80.00+5.3% |
|
Jul 08
00:20 UTC
|
HUM
Humana
|
◎ Target | Sarah James ★★★★☆ #846 | Neutral | $264.00→ $300.00+13.6% |
|
Jul 08
00:20 UTC
|
HON
Honeywell International
|
◎ Target | Chigusa Katoku not yet tracked | Overweight | $260.00→ $250.00-3.8% |
|
Jul 08
00:20 UTC
|
HG
Hamilton Insurance Group
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Overweight | $37.00→ $39.00+5.4% |
|
Jul 08
00:20 UTC
|
HCM
HUTCHMED
|
◎ Target | Alec Stranahan ★★☆☆☆ #2345 | Buy | $20.00→ $17.00-15.0% |
|
Jul 08
00:20 UTC
|
HCA
HCA Healthcare
|
◎ Target | Sarah James ★★★★☆ #846 | Overweight | $588.00→ $525.00-10.7% |
|
Jul 08
00:20 UTC
|
HBAN
Huntington Bancshares
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $21.00→ $22.00+4.8% |
|
Jul 08
00:20 UTC
|
HAIN
The Hain Celestial Group
|
◎ Target | Kaumil Gajrawala ★★★★☆ #567 | Hold | $1.03→ $0.81-21.4% |
|
Jul 08
00:20 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Ebrahim Poonawala ★★★☆☆ #1726 | Buy | $1,050.00→ $1,150.00+9.5% |
|
Jul 08
00:20 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Neutral | $940.00→ $1,120.00+19.1% |
|
Jul 08
00:20 UTC
|
GLW
Corning
|
◎ Target | Martin Yang ★★★☆☆ #1217 | Outperform | $210.00→ $230.00+9.5% |
|
Jul 08
00:20 UTC
|
GILD
Gilead Sciences
|
◎ Target | Brian Abrahams ★★☆☆☆ #2651 | Sec→ r Perform | $122.00→ $120.00-1.6% |
|
Jul 08
00:20 UTC
|
GILD
Gilead Sciences
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $157.00→ $156.00-0.6% |
|
Jul 08
00:20 UTC
|
G
Genpact
|
◎ Target | David Koning ★★★★☆ #536 | Neutral | $45.00→ $38.00-15.6% |
|
Jul 08
00:20 UTC
|
FTT
Finning International
|
◎ Target | firm only | Sec→ r Outperform | C$114.00→ C$118.00+3.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.